Pfizer’s Myositis Research
Do you have patients with Dermatomyositis or Polymyositis who may be eligible to participate in an ongoing Phase 3 clinical research study?
• This study is currently recruiting in 9 states in the USA and will add additional sites in the USA and internationally.
• Additional details about the study (NCT05895786; Protocol number C0251006) can be found at https://clinicaltrials.gov/study/NCT05895786 .
Sponsored by Pfizer Inc